A case (report) for mechanistic validation of meningioma molecular therapies is a research paper published in Neuro-Oncology Advances (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: F30 CA246808
NIH
Grant: T32 GM007618
NIH
Grant: R01 CA262311
NCI NIH HHS
Grant: T32 CA151022
National Institutes of Health
Grant: 5T32GM007618-27
MEDICAL SCIENTIIST TRAINING PROGRAM
National Institutes of Health
Grant: 5R01CA262311-03
Understanding druggable drivers of meningioma tumorigenesis
National Institutes of Health
Grant: 5F30CA246808-04
Investigating the Regulation and Role of FOXM1 in Aggressive Meningioma
ASCO Conquer Cancer Young Investigator
Chan-Zuckerberg Biohub Physician Scientist Fellowship
Neurosurgery Research and Education Foundation Research Fellowship
UCSF Wolfe Meningioma Program Project
Glioblastoma Foundation Neil Peart Research Award
UCSF Brain Tumor Center SPORE
UCSF Catalyst Program
ASCO Conquer Cancer Young Investigator Award in Drug Development
FWCI
0.31
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords